z-logo
open-access-imgOpen Access
Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes
Author(s) -
Brian Dobosh,
Keivan Zandi,
Diego Moncada Giraldo,
Shu Ling Goh,
Kathryn L. Musall,
Milagros Aldeco,
Julia C. LeCher,
Vincent D. Giacalone,
Junkai Yang,
Devon J. Eddins,
Manoj Bhasin,
Eliver Ghosn,
Vikas P. Sukhatme,
Raymond F. Schinazi,
Rabindra Tirouvanziam
Publication year - 2022
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2022.110945
Subject(s) - proinflammatory cytokine , covid-19 , lung , immunology , medicine , inflammation , infectious disease (medical specialty) , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom